Catabasis Pharmaceuticals, Inc.

Cambridge, MA 02139

Market Performance

Market Cap $45.9 Million
52 Week High $5.51
52 Week Low $1.08

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $180K
First Award Date 09/16/10
Most Recent Award Date 09/16/10

Key Personnel

Last Name Name Awards Contact
Jirousek Michael Robert Jirousek 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 09/16/10 - 08/30/11

DESCRIPTION (provided by applicant): 5-Aminosalicylic acid (5-ASA) and its analogs such as the prodrug sulfasalazine are front line therapy for Inflammatory Bowel Disease (IBD), which include both Crohn's disease and ulcerative colitis. 5-ASA is only moderately efficacious in putting patients into remission and the doses of 5-ASA required are qu...